Patents by Inventor Mark Benyunes

Mark Benyunes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090041788
    Abstract: Methods of using synergistically effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells, are provided.
    Type: Application
    Filed: October 14, 2008
    Publication date: February 12, 2009
    Applicant: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Mark Benyunes, Ralph Schwall
  • Publication number: 20070026000
    Abstract: Methods of using synergistically effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Applicant: Genentech, Inc.
    Inventors: Avi Ashkenazi, Mark Benyunes, Ralph Schwall
  • Publication number: 20060240008
    Abstract: The present application describes therapy with antagonists which bind to B cell surface markers, such as CD20. In particular, the application describes the use of such antagonists to treat autoimmune disease in a mammal who experiences an inadequate response to a TNF?-inhibitor.
    Type: Application
    Filed: May 24, 2006
    Publication date: October 26, 2006
    Inventor: Mark Benyunes
  • Publication number: 20040228868
    Abstract: Methods of using synergistically effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: June 17, 2004
    Publication date: November 18, 2004
    Applicant: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Mark Benyunes, Ralph Schwall